Caris Life Sciences (CAI) Change in Cash (2024 - 2026)

Caris Life Sciences' Change in Cash history runs 3 years deep, the most recent figure standing at $23.3 million for Q1 2026.

• On a quarterly basis, Change in Cash rose 171.32% year-over-year to $23.3 million in Q1 2026; TTM through Mar 2026 was $788.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $732.0 million, up 9026.22% from the prior year.
• Change in Cash eased to $23.3 million in Q1 2026 per CAI's latest filing, from $43.1 million in the prior quarter.
• Across five years, Change in Cash topped out at $687.4 million in Q2 2025 and bottomed at -$71.2 million in Q3 2024.
• The 3-year median for Change in Cash is $23.3 million (2026), against an average of $91.9 million.
• Biggest YoY gain for Change in Cash was 205.06% in 2025; the steepest drop was 148.18% in 2025.
• Year by year, Change in Cash stood at -$41.0 million in 2024, then jumped by 205.06% to $43.1 million in 2025, then plunged by 45.78% to $23.3 million in 2026.
• Per Business Quant, the three latest CAI Change in Cash figures stand at $23.3 million (Q1 2026), $43.1 million (Q4 2025), and $34.3 million (Q3 2025).